Latest news
Oral SERDs Face the Hard Test: Where Do They Actually Fit?
ASCO 2026 giredestrant updates show why oral SERDs remain promising in ER-positive breast cancer, but also why stage, sequence and resistance biology matter.
Obesity Care Starts Moving Beyond BMI
Canada’s Generic Semaglutide Approval Tests GLP-1 Affordability
India’s Obesity Campaign Dispute Tests the Line Between Awareness and Promotion
England’s Tirzepatide Rollout Shows Approval Is Not Access
Medicare’s GLP-1 Bridge Turns Obesity Coverage Into a Public-Payer Experiment
WHO Makes Obesity Treatment a Global Access Test
Cyberbullying Becomes a Youth Mental Health Policy Target
Alzheimer’s Agitation Gets a New Drug, But Care Pathways Still Lag
Rare Epilepsy Moves Toward Treating the Cause
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.